SK Biopharmaceuticals Co., Ltd. (KRX:326030)
128,900
-100 (-0.08%)
At close: Dec 19, 2025
21.26% (1Y)
| Market Cap | 10.09T |
| Revenue (ttm) | 675.41B |
| Net Income (ttm) | 320.47B |
| Shares Out | 78.31M |
| EPS (ttm) | 4,092.19 |
| PE Ratio | 31.50 |
| Forward PE | 40.68 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 189,503 |
| Average Volume | 272,172 |
| Open | 129,600 |
| Previous Close | 129,000 |
| Day's Range | 127,500 - 130,600 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.77 |
| RSI | 45.93 |
| Earnings Date | Feb 4, 2026 |